Strides Pharma Science’s step?down wholly owned subsidiary, Strides Pharma Global Pte., Singapore, has received approval for Polyethylene Glycol 3350 and Electrolytes for Oral Solution USP, 236 grams/2.97 grams/6.74 grams/5.86 grams/22.74 grams/4 Liter from the United States Food & Drug Administration (USFDA). The product is a generic version of GoLYTELY of Braintree Laboratories, Inc.
The company has 80 cumulative ANDA filings with USFDA of which 55 ANDAs have been approved including 11 approvals received in FY 19.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
